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Abstract 
Objective: In cases of complex regional pain syndrome where conservative treatment is unsuccessful in controlling neuropathic foot pain 
spinal cord stimulation may be considered. To our knowledge there have been no such cases reported in the foot & ankle literature. The aim 
of the study was to establish useful information that may supplement our understanding of this complex multifactorial problem and help to 
inform future management of similar cases.  
Methods: A pilot observational case series study was undertaken to investigate the use of spinal cord stimulation in the management of 
neuropathic foot pain using five cases with complex regional pain syndrome (type I).  
Results: Reduced pain following spinal cord stimulation was reported. The interval between diagnosis and commencement of spinal cord 
stimulation was variable between cases and maybe responsible for differing levels and timing of pain relief experienced. 
Conclusion: Careful preoperative diagnosis, robust patient selection and close postoperative monitoring are vital for a successful outcome. 
The small sample size and potential for bias, limit the generalizability to a larger population. A larger study is therefore indicated to expand 
upon preliminary findings.  
 
Key Words: Complex Regional Pain Syndrome; Spinal Cord Stimulation; Neuropathic pain; Foot; Management.  
Resumen 
Objetivos: En los casos de síndrome de dolor regional complejo en el que el tratamiento conservador no tiene éxito en el control del dolor en 
el pie neuropático la estimulación de la médula espinal puede ser considerado. Para nuestro conocimiento no ha habido tales casos reportados 
en la literatura vinculada a los pies y los tobillos. El objetivo del estudio fue establecer información útil que puede complementar nuestra 
comprensión de este complejo problema multifactorial y ayudar a informar a la futura gestión de casos similares. 
Material y  métodos: Un observacional piloto estudio de series de casos se realizó para investigar el uso de estimulación de la médula 
espinal en el tratamiento del dolor neuropático pies usando cinco casos con síndrome de dolor regional complejo (tipo I).  
Resultados: Se informó de una reducción del dolor después de la estimulación de la médula espinal. El intervalo entre el diagnóstico y el 
inicio de la estimulación de la médula espinal fue variable entre los casos y tal vez responsable de los diferentes niveles y tiempos de alivio 
del dolor experimentado.  
Conclusión: El Diagnóstico preoperatorio cuidadoso, la selección de pacientes y el seguimiento postoperatorio son vitales para un 
resultado exitoso. El tamaño pequeño de la muestra y la posibilidad de sesgo, limitan la posibilidad de generalizar a una población mayor. 
Por tanto, un estudio más amplio está indicado para expandir los hallazgos preliminares. 
 
 
Palabras Clave: Síndrome de Dolor Regional Complejo; Estimulación de la médula espinal; Dolor neuropático; Pie; Administración. 
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Introduction  
 
Neuropathic lower limb pain constitutes a 
significant portion of chronic pain and is an 
important, prevalent, and multifaceted problem. 
Numerous research studies have examined the 
complexities of chronic neuropathic pain (1-4).  
 
Neuropathic pain arises from damage, or 
pathological change, in the peripheral or central 
nervous system (1). It is usually a chronic 
condition that can be difficult to treat because 
standard treatment with conventional analgesics 
does not typically provide effective relief of pain.  
 
Neuropathic pain places a large cost burden on 
healthcare services and is usually associated with 
substantially greater impairment of quality of life 
compared with other types of chronic pain (1). The 
role of the spinal cord stimulation (SCS) in 
managing chronic neuropathic pain has been 
widely reported in the literature and is supported 
by evidence-based research (5-9). Spinal cord 
stimulation is a treatment used for chronic pain 
that uses a mild electric current to block nerve 
impulses in the spine. Stimulating electrodes are 
placed through a needle into the spine near the 
spinal cord and activated to provide a mapped 
paraesthesia in the painful area (9).  
 
In the case of lower limb pain, the usual electrode 
position is T10-12 vertebral level. A two-step 
procedure is undertaken with a test phase before 
implantation of the Impulse Generator (IPG). 
Spinal cord stimulation has been reported to 
improve the subjective symptoms of the 
neuropathic foot pain of complex regional pain 
syndrome, enable objective functional 
improvement and reduces analgesic consumption 
(6-9). Spinal cord stimulation is generally reserved 
for patients who have CRPS, which is refractory 
to conventional conservative management (8). It is 
a relatively safe procedure and reversible with 
implant removal.  
 
 
 
 
The neuromodulatory technique of SCS has 
evolved as a direct clinical application of the gate-
control theory, the general conceptualization of 
which still provides the framework in explaining 
its mode of action (9). 
 
A pilot observational case series study was 
undertaken of patients with neuropathic foot pain 
who had developed complex regional pain 
syndrome (type I) who were currently being 
managed by use of spinal cord stimulation (SCS). 
The diagnosis of complex regional pain syndrome 
(CRPS) was defined using clinical examination, a 
set of clinical diagnostic standards known as the 
Budapest criteria, hospital investigations and a 
validated pain assessment (1,6). The principal 
objective of the study was to undertake a detailed 
retrospective review of the case notes of a series 
of participants with neuropathic foot pain and 
establish the value of its management using SCS.  
 
This was undertaken by carefully retrospectively 
examining and extracting anonymised data from 
the patients’ medical records. The case series 
study was used to examine the multifaceted 
approach to the management of neuropathic foot 
pain with particular reference to the impact and 
value of the spinal cord stimulation. Its aim was to 
establish useful information that may supplement 
our understanding of this complex multifactorial 
problem and help to inform future management of 
similar cases. 
 
Materials and methods  
  
A pilot observational case series design was used 
to retrospectively collect data from patients’ 
medical records (as part of routine clinical care 
and response to SCS) presenting with intractable 
foot pain due to Complex Regional Pain 
Syndrome - type 1 (CRPS-I). All patient were 
being treated with Spinal Cord Stimulation. 
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This design highlights patients with a specific 
condition who has been given similar treatments 
and enabled the researchers to review the patients’ 
medical records and chart retrospectively the 
medical history of their condition. No additional 
procedures or questioning were carried out for the 
purposes of data collection. Consecutive sampling 
was applied. Prof Raphael (JHR) recruited 
sequential patients with CRPS treated by spinal 
cord stimulation from the weekly pain review 
clinics at Russells Hall Hospital (RHH) 
Birmingham UK. The duration of patient 
recruitment was over a defined two-month period. 
 
Ethical committee approved was obtained from 
London – City & East. 
 
Inclusion criteria: Males and females, 18 to 85 
years-of-age, chronic neuropathic foot pain, fitted 
with spinal cord stimulator. Exclusion criteria: 
Cancer pain, chronic back and limb pain, upper 
limb pain, diabetes, not fitted with spinal cord 
stimulator, other interventional procedures 
(intrathecal drug delivery or other types of 
neurostimulation). 
 
Study participants were identified from those 
patients attending the pain clinic at RHH. 
Specialist centres such as this treat a range of 
pathologies presenting with neuropathic pain and 
have sufficient numbers of patients to warrant a 
closer examination of the variables that may 
influence management. The clinical care team 
under the guidance of JHR selected appropriate 
cases. Ethical approval was granted and written 
consent obtained. Participants were approached by 
the clinical care team to obtain consent to use data 
from their medical records.  
 
The data was extracted and collated in anonymised 
form to ensure confidentiality. This included basic 
demographic data (gender, age, location/duration 
of pain, cause of pain, medication), a summary of 
the medical history to date and details of the SCS 
technology used.  
 
 
 
 
Validated outcome measures were used to 
evaluate the progress of patients following the 
intervention of SCS. An online consumer 
classification (http://acorn.caci.co.uk/) was 
applied to assess the patients’ home environment. 
This segments the UK population into 
neighbourhoods (six categories, 18 Groups and 62 
types, three of which are not private households) 
based on postcodes and provides an analysis of 
social factors and population behaviour.  
 
Validated clinical tools were used to confirm 
diagnosis including the Budapest criteria, 
thermography and X-ray’s. The validated outcome 
measures applied to measure pain levels, anxiety 
and depression include: Visual Analogue Scale 
(VAS), Brief Pain Inventory (BPI), Hospital 
Anxiety and depression scale (HADS), Coping 
Strategy Questionnaire (CSQ). 
 
 
Results 
 
Reduced pain following spinal cord stimulation 
was reported in all cases. The interval between 
diagnosis and commencement of spinal cord 
stimulation was variable between cases and maybe 
responsible for differing levels and timing of pain 
relief experienced by the different cases reported. 
Much of what was reported in the patient’s case 
notes was descriptive qualitative data. 
 
In all cases the pain levels documented (Visual 
Analogue Scales and Brief Pain Inventory) were 
found to have reduced following implementation 
of Spinal Cord Stimulation (SCS). In addition the 
levels of anxiety and depression documented by 
the Hospital Anxiety and Depression Scale and 
Coping Strategy Questionnaire were found to have 
reduced after use of SCS. The patient’s ability to 
cope with chronic pain was influenced by their 
levels of anxiety and depression. 
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Cases 
 
Case 1 
 
A 67-year-old Caucasian female presented with a 
history of neuropathic pain. This had been 
diagnosed as possible CRPS type 1 at 61 years-of–
age following left foot hammertoe surgery in 
2008. Her home environment was graded as 
category five (Urban adversity, struggling estate, 
financially poor). 
 
The patient underwent a lumbar sympathetic block 
in combination with anti-neuropathic medications. 
Benefits were reported as transiently with 
numbness in the foot for a short time. In May 2009 
on examination the left foot presented as swollen, 
dusky in colour and colder than the ipsilateral 
limb. Allodynia was present across the entire 
dorsum of the foot with patch allodynia in the 
inter-malleolar region.  She was unable to wear 
socks and used a padded foot splint.  
 
Pharmacological management included 
Oxycontin, Pregabalin and Paracetamol. In 
November 2009 a psychologist assessed the 
patient.  She was anxious and tearful at 
consultation saying her quality of life was poor 
and that she spent most of the day in bed. She 
scored 17 on the Hospital and Anxiety Depression 
scales (HADS). She was found to have signs of 
depression and referred to a psychiatrist for her 
anxiety.  She was reviewed every three months.  
 
The patient was recommended to increase 
Nortriptyline slowly. Lidocaine medicated 
patches (Versatis) were given to wear for 12 hours 
per day. A diagnosis of CRPS (type 1) was 
confirmed based upon the Budapest criteria. At 
this point in time her condition had been present 
for two years. It was explained to the patient and 
her family at her pain clinic consultation that the 
symptoms of pain were not going to subside 
without further interventions.  
 
 
 
 
 
In early August 2010 she was admitted to hospital 
for a stage one SCS procedure and the SCS 
electrodes were implanted at thoracic vertebrae 
level 10. Octopolar nerve stimulation was 
provided for one week and her Visual Analogue 
Scale dropped from 8-9/10 to 1-2/10. On 26th 
August 2010 she underwent a stage two procedure 
to implant the Impulse Generator (IPG). She was 
discharged on 31st August. She was reviewed one-
month later. She had responded well to SCS and 
her mobility had improved.  Full coverage over the 
painful area had been achieved.  The lidocaine 
patches were withdrawn at this stage. In July 2011 
the patient reported 75% pain relief.  She was still 
reliant on a wheelchair and crutches due to a loss 
of proprioception and balance. In February 2012 
the pain relief had reduced to 50-60%. In July 
2012 pain had reduced from 8-9/10 to 1-2/10 and 
the patient was able to tolerate bedclothes and in 
August 2012 her pain had reduced from 9/10 to 
3/10 (VAS). At the last review in December the 
patient reported that ongoing relief of pain was 
good and that function was satisfactory. 
 
Case 2 
 
A 49-year-old Caucasian female presented with 
neuropathic pain in her right foot, back and right 
elbow and had a past medical history of pernicious 
anaemia. She worked as a housewife and her home 
environment was graded as category four 
(financially stretched, rural council estate).  
 
The symptoms of neuropathic pain were 
precipitated by a road traffic accident in 2008. She 
was referred to orthopaedics in 2011 complaining 
of generalized pain in most joints. Inflammatory 
arthropathy and possible fibromyalgia were 
considered. Pain symptoms were managed 
pharmacologically with Ibuprofen, Capascin, 
Oramorph, Gabapentin and a lumbar sympathetic 
block.  
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Following a referral by her General Practitioner 
(GP) to the pain clinic for further evaluation a 
diagnosis of CRPS (Type 1) was confirmed. The 
diagnosis of CRPS was confirmed based upon the 
Budapest criteria. In 2011 the patient had a 
psychological evaluation on the pain clinic and 
was found to be anxious and uncomfortable in 
crowed places. It was found that she had difficulty 
coping with her overall pain and woke in the 
mornings with pains in her hands but had no 
swelling. She also suffered occasional sweating 
and palpitations. Plain X-rays were normal. The 
patient was referred for physiotherapy and a 
Rheumatology consultation excluded any 
underlying rheumatological pathology. 
 
Due to ongoing severity and magnitude of pain the 
patient was considered for SCS. In May 2012 she 
underwent a full psychological evaluation and was 
found to demonstrate a robust psychological 
profile with no psychological barriers to SCS. In 
March 2014 she was admitted for a stage one 
procedure to implant the electrodes. This was 
followed by a stage two procedure to implant the 
impulse generator (IPG). An evaluation of 
activities of daily living (ADL) was undertaken to 
provide a baseline against which subsequent 
assessment could be measured. She was then 
reviewed in May 2014 and the SCS was found to 
have good coverage. The patient reported a 
reduction in pain levels by 50%. At a follow up in 
November 2014 she had not been walking for the 
past two weeks. Her abdomen was painful at the 
operative site near the IPG but there were no signs 
of infection. In January 2015 she was reviewed, X-
rays revealed that the leads were correctly sited.  
 
Skin colour changes were present over her 
buttock. These were not painful and considered to 
be related to the CRPS rather than infection. The 
patient was advised to take photographs to 
monitor. 
 
 
 
 
 
 
 
 At a subsequent review technical support was 
provided to help re-program the IPG and any non-
functioning electrodes. The patient reported that 
the function of the SCS was impaired when she 
bent over suggesting loose connections at the IPG. 
The technician modified the SCS program to 
include adaptive stimulation with regard to body 
position and further X-rays were taken to check 
that leads had not become disconnected.  
 
 
Case 3 
 
A 41-year-old Caucasian female presented in 2002 
following a crush injury that she sustained to her 
right foot. She was found to have ligament damage 
but no fracture. A diagnosis of CRPS (type 1) was 
confirmed based upon the Budapest criteria. 
Clinical examination revealed a varus deformity 
of the right ankle. She worked as a housewife and 
her home environment was graded as category five 
(Urban adversity, struggling estate, financially 
poor). 
 
Management of the condition included an 
intravenous injection of Guanethidine followed by 
a chemical sympathectomy at the third lumbar 
vertebrae level in 2003. The right foot developed 
an equinus deformity, which was treated with a 
cast and course of physiotherapy to stretch out the 
tight posterior structures of the ankle and leg. In 
2011 due to ongoing pain in the right foot the 
patient initially underwent a right first 
metatarsophalangeal joint cheilectomy and 
calcaneo-cubiod arthrodesis. Due to persistent 
right ankle pain she underwent a talectomy and 
calcaneotibial fusion. 
 
Due to on-going pain in the right foot a spinal cord 
stimulator (SCS) was implanted in January 2015 
at the tenth thoracic vertebrae level. In July 2015 
the patient reported a 70% pain reduction The SCS 
settings used were cathode 5, anode -6, 169 Hz, 
frequency 40Hz. 
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Pharmacological management included the use of 
Tramadol, Naproxen, Amitriptyline and 
Pregabalin.  
 
 
Case 4 
 
A 62-year-old Caucasian male presented with a 
history of a left ankle fracture in 2003. His home 
environment was graded as category four 
(financially stretched, rural council estate). Due to 
ongoing left ankle pain an arthroscopy was 
undertaken in 2011. This revealed medial gutter 
synovitis but no joint damage.  An MRI of the left 
ankle was found to be normal. His symptoms of 
ankle pain were initially managed with Ibuprofen 
and co-dydramol. Due to persistence of symptoms 
he underwent a talonavicular joint steroid 
injection. 
 
 In April 2013 he was referred to the pain clinic as 
his symptoms of ankle pain were deteriorating. 
Clinical examination revealed that the left foot/ 
ankle was sensitive to touch; temperature and 
colour changes and swelling were also evident. A 
diagnosis of CRPS (type 1) was confirmed based 
upon the Budapest criteria.  
 
Pharmacological management was initiated, this 
included Tramadol and Dihydrocodeine. As this 
was not successful in managing symptoms 
Amitriptyline, Gabapentin and Pregabain were 
added. Lidocaine medicated patches (Versatis) 
were also tried. A chemical sympathectomy was 
undertaken but this provided no benefit. 
 
In July 2013 a bone scan of the left ankle was 
undertaken. This revealed increased activity over 
the left ankle. Due to ongoing symptoms of pain a 
spinal cord stimulator was implanted in November 
2014. This was reviewed in January 2015.  It was 
reported that neuropathic pain symptoms had 
reduced from 8/10 to 1/10 (VAS). 
 
 
 
 
 
 
Case 5 
 
A 48-year-old Caucasian female, presented with 
neuropathic pain in her left foot. This had been 
present for three years. She was a housewife. Her 
home environment was graded as category four 
(financially stretched, urban council estate). The 
patient had undergone left hallux valgus surgery in 
2011 and following this she had developed a 
chronic pain syndrome in her left foot. Pregabalin 
and Tramadol were initially used to manage the 
neuropathic pain symptoms.  
 
As a result of progression of pain symptoms and 
disability she was referred to the Royal National 
Hospital for Rheumatic Disease, where a primary 
diagnosis of CRPS (type 1), and secondary 
diagnosis of plantar fasciitis were made. 
Subsequently she was referred to the pain 
medicine clinic at Russells Hall Hospital. On 
examination she presented with colour, 
temperature and nail changes in the left foot. Also 
oedema, excess sweating, hyperalgesia and 
allodynia were evident. In addition foot equinus/ 
overriding toe deformities and dystonia presented. 
All clinical features met the Budapest criteria 
confirming the diagnosis of CRPS (type 1). 
Pharmacological management was initiated to 
control pain and manage symptoms of depression 
and anxiety. This consisted of Codeine, 
Gabapentin, Amitriptyline, Disodium 
Pamidronate infusion, Duloxetine and 
Guanethidine.  
 
 
The multidisciplinary team managing the patient 
consisted of a pain consultant, psychologist, 
psychiatrist and physiotherapist. Due to ongoing 
severity and magnitude of pain the patient was 
considered for a SCS. She underwent a 
psychological evaluation in May 2014 and 
demonstrated a robust psychological profile and 
presented with no psychological barriers to SCS.  
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During her hospital admission an evaluation of 
activities of daily living was undertaken to assess 
her functional abilities. A number of validated 
measuring tools were used to quantify neuropathic 
pain and the levels of anxiety and depression 
experienced. The pain was rated as 10/10 using the 
Visual Analogue scale. The Brief Pain Inventory 
(BPI) long form rated pain as 9/10. The BPI 
measures both the intensity of pain (sensory 
dimension) and interference of pain in the patient's 
life (reactive dimension). It also queries the patient 
about pain relief, pain quality, and patient 
perception of the cause of pain. The Hospital 
Anxiety and Depression Scale (HADS) (10, 11) 
was also used, this was rated as 12/21. In addition 
the Coping Strategies Questionnaire (CSQ) was 
completed to evaluate the patients’ ability to deal 
with her adjustment to chronic pain.  
 
In December 2014 she underwent a stage one 
procedure to implant the octopolar (eight pole) 
lead at vertebral level T10. X-rays revealed that 
the leads were correctly sited and these were tested 
using an external controller to establish their 
patency. Following a successful trial period 
(>50% pain relief during one week trial) a stage 
two procedure was undertaken for implantation of 
the impulse generator (IPG) (Advanced Bionics 
Precision SC-1110) and at a following review 
technical support was provided to check the 
function of the SCS. The patient was reviewed at 
one month to test coverage of the foot and check 
the settings (cathode at contact 4 (100%) and 
anode at contact 3 (100%) of octopolar lead; area 
(left lower limb), 3.5mA level, 210μs pulse width, 
60Hz rate, 2.4 volts). She was found to have 25% 
relief of symptoms but still some muscle spasms.  
 
This was considered to be a normal finding at only 
one month post-implant. Normally patients are 
expected to experience increased levels of pain 
relief (>50%) with time. A subsequent technical 
review to re-program the IPG to establish 
improved SCS function was undertaken. 
 
 
 
      Discussion 
  
This case series study demonstrates the value of 
using SCS for managing a range of complex 
neuropathic foot pain where standard treatment 
modalities have failed to control symptoms. The 
potential benefits of this particular treatment 
modality are revealed in the case series presented. 
Patients suffering from CRPS (type I) were found 
to experience a reduction in their symptoms of 
neuropathic foot pain when using SCS, where 
other treatment modalities had failed. Indeed 
several cases experienced long term relief of their 
symptoms as a result of using SCS. Although not 
seen in this series some patients can experience 
spontaneous lead breakage with insulation failure 
or radiographic lead migration and a subsequent 
stimulation loss in SCS (12, 13). This can lead to 
the need for revision surgery. Advances in surgical 
techniques and use of silicone anchors help reduce 
revision rates (12, 13). 
  
This case series provides information to help 
inform the future management of similar CRPS 
cases. It is appreciated that the implications for 
management need careful consideration due to the 
small sample size and potential for bias, limiting 
its generalizability to a larger population of 
patients. It is also appreciated that the quality of 
data obtained from a pilot observational case 
series study has limitations due to confounding 
factors.  
 
However, the use of SCS is evidence-based and 
remains a valuable treatment modality, and should 
be considered in cases where conservative 
management has failed. The findings of a recent 
study support the use of SCS in CRPS (type I) 
(14). A careful preoperative diagnosis and robust 
patient selection is vital for the success of this 
method. The psychological profile of patients who 
are chosen for SCS must be taken into account (9).  
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Spinal cord stimulation requires close patient 
monitoring postoperatively. Prudent aftercare is 
indicated, as reprogramming surveillance may be 
necessary to deal with any complications.  
 
Future technological progress in the application 
of SCS has led to improved stimulation patterns 
adapted to the patients’ needs. It also enables 
better control of the chronic symptoms that result 
from this complex neuropathic pain syndrome.  
 
Conclusions  
 
Neuropathic lower limb pain constitutes a 
significant portion of chronic pain and is an 
important problem that needs to be carefully 
managed. A pilot observational case series study 
was undertaken of patients with neuropathic foot 
pain who had developed complex regional pain 
syndrome (type I) who were currently being 
managed by use of spinal cord stimulation (SCS). 
Reduced pain following spinal cord stimulation 
was reported.  
 
In addition the levels of anxiety and depression 
were found to have reduced after use of SCS. The 
patient’s ability to cope with chronic pain was 
influenced by their levels of anxiety and 
depression. The interval between diagnosis and 
commencement of spinal cord stimulation was 
variable between cases and maybe responsible 
for differing levels and timing of pain relief 
experienced. 
 
The development of a larger prospective study to 
control for confounding variables is being 
considered so as to expand upon the preliminary 
findings of this pilot observational case series 
study. 
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